Jump to content

Aurotioprol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Cydebot (talk | contribs) at 05:49, 17 May 2019 (Robot - Speedily moving category Gold(Ⅰ) compounds to Category:Gold(I) compounds per CFDS.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Aurotioprol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Intramuscular injection
ATC code
Identifiers
  • Sodium aurothiopropanolsulfonate
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.043.971 Edit this at Wikidata
Chemical and physical data
FormulaC3H6AuNaO4S2
Molar mass390.16 g·mol−1
3D model (JSmol)
  • C(C(CS(=O)(=O)[O-])O)[S-].[Na+].[Au+]
  • InChI=1S/C3H8O4S2.Au.Na/c4-3(1-8)2-9(5,6)7;;/h3-4,8H,1-2H2,(H,5,6,7);;/q;2*+1/p-2
  • Key:KBWWFTIQBJUOQR-UHFFFAOYSA-L
  (verify)

Aurotioprol is a gold salt used as an antirheumatic agent.[1][2]

References

  1. ^ Perrier, P.; Raffoux, C.; Thomas, P.; Tamisier, J. N.; Busson, M.; Gaucher, A.; Streiff, F. (1985). "HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis". Annals of the Rheumatic Diseases. 44 (9): 621–624. doi:10.1136/ard.44.9.621. PMC 1001721. PMID 3876081.
  2. ^ Veys, E. M.; Mielants, H.; Verbruggen, G. (1987). "Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study". Clinical and experimental rheumatology. 5 (2): 111–116. PMID 3608266.


Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Aurotioprol&oldid=897460655"